Novadiscovery services

Select the right target. Explore combinations of target/treatments. Support the translation from animal to man.

Demonstrate value to payers. Transpose Phase 3 trial results into an estimation of the drug’s public health impact. Benchmark against competing treatments.

Explore various regimens (dose, number of administrations per day, time between administrations, duration of treatment). Identify subgroups of optimal responders / theranostic biomarkers. Leverage real-world data to inform clinical trial design.